Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23 January). NICE has recommended talazoparib ...

The Phase 1 clinical trial, STRIKE-001 (NCT07103018), is a multi-center, open-label dose escalation of KTX-2001 monotherapy (Part A) and in combination with darolutamide, an oral, nonsteroidal ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

AUSTIN (KXAN) — More people have been diagnosed with prostate cancer following years of decline. In a recent annual report from the American Cancer Society, it said that the statistics for prostate ...

City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with ...

A top oncologist explains the early prostate cancer signs that men over 40 must watch for. From urinary changes to ...